newsfilter
← Latest News
Business Wire·

Saptalis Pharmaceuticals Announces the Launch of LIKMEZ® — The First and Only US FDA-Approved Ready-to-Use Oral Suspension of Metronidazole

Saptalis Pharmaceuticals LLC proudly announces the launch of LIKMEZ® (metronidazole) oral suspension, 500 mg/5 mL (100 mg/ mL), an innovative liquid formulation developed specifically for patients with difficulty